ghk-cu molecule – Research Peptide GHK-Cu (Copper Peptide) - Source307

Expect at least 46 weeks of treatment for most cases

Patients should be prepared to discuss medical history, current medications, previous treatments, wellness goals, and recent lab work if available

Anecdotal reports from healthcare providers and patient communities suggest that mild bruising may occur more frequently in everyday practice, though most cases are minor and resolve without intervention

This underscores why GHK-Cu research protocols consistently emphasize working at carefully controlled, low, non-toxic concentrations rather than assuming "more is better." Regulatory Status As of the most recent literature reviews, GHK-Cu remains classified primarily as a cosmetic ingredient rather than an FDA-approved drug